PEMFEXY Trademark

Trademark Overview

On Tuesday, September 15, 2020, a trademark application was filed for PEMFEXY with the United States Patent and Trademark Office. The USPTO has given the PEMFEXY trademark a serial number of 90182483. The federal status of this trademark filing is REGISTERED as of Tuesday, June 7, 2022. This trademark is owned by Eagle Pharmaceuticals Inc.. The PEMFEXY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of lung cancer
pemfexy

General Information

Serial Number90182483
Word MarkPEMFEXY
Filing DateTuesday, September 15, 2020
Status700 - REGISTERED
Status DateTuesday, June 7, 2022
Registration Number6755182
Registration DateTuesday, June 7, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of lung cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 22, 2020
Primary Code005
First Use Anywhere DateTuesday, February 1, 2022
First Use In Commerce DateTuesday, February 1, 2022

Trademark Owner History

Party NameEagle Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWoodcliff Lake, NJ 07677
Party NameEagle Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWoodcliff Lake, NJ 07677
Party NameEagle Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoodcliff Lake, NJ 07677

Trademark Events

Event DateEvent Description
Wednesday, August 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 16, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 16, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 5, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 5, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 6, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 7, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 7, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, May 5, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, May 4, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 20, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 6, 2022USE AMENDMENT FILED
Tuesday, April 19, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 6, 2022TEAS STATEMENT OF USE RECEIVED
Friday, October 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 27, 2021SOU EXTENSION 1 GRANTED
Wednesday, October 27, 2021SOU EXTENSION 1 FILED
Wednesday, October 27, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 28, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 28, 2021ASSIGNED TO LIE
Thursday, January 28, 2021ASSIGNED TO LIE
Wednesday, January 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 27, 2021ASSIGNED TO EXAMINER
Thursday, October 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 18, 2020NEW APPLICATION ENTERED

Related Keywords

pemfexy cancer lung treatment preparations pharmaceutical